HORMONE THERAPY BRANDS
Launch a hormone therapy brand on Tessic Health
Tessic Health runs the clinic behind a hormone therapy brand. Licensed providers diagnose from lab results and prescribe in all 50 states, testosterone moves over EPCS to DEA-registered pharmacies, and patients buy through a storefront with your name on it. One brand can run men's testosterone therapy and menopause hormone therapy side by side.
50
States with licensed providers
EPCS
Controlled-substance prescribing
2
Morning tests before a TRT diagnosis
$25
Flat per completed consult
CLINICAL
What your hormone therapy patients get
Hormone programs are driven by lab results from the first visit, and they stay that way for as long as the patient is treated.
01
Diagnosis from lab results
Testosterone therapy starts with two early-morning total testosterone tests on separate days, as Endocrine Society and American Urological Association guidelines call for, plus a blood count and PSA where indicated.
02
A video visit before testosterone
Every new testosterone patient meets a provider by video before a controlled substance is prescribed.
03
Contracted labs
Patients draw at contracted lab sites, and results post straight to the chart for the provider to review.
04
Checkups on a schedule
Testosterone, hematocrit and PSA are rechecked on the guideline schedule, typically three to six months after starting and then yearly. Testosterone labels include blood pressure warnings, so blood pressure is tracked too. Providers adjust or pause therapy when results call for it.
05
Menopause treatment
Providers treat hot flashes, sleep problems and vaginal symptoms with estrogen, progesterone and non-hormonal options, weighing each patient's history of blood clots, stroke and breast cancer.
06
Options that protect fertility
Men who want to keep their fertility can be treated with medications that keep their own testosterone production running, such as clomiphene.
MEDICATIONS & PROTOCOLS
What your providers can prescribe
Hormone programs on Tessic start from the medications below. Providers choose among them for each patient after an evaluation and lab review.
| Medication | Form | Used for | How it is filled |
|---|---|---|---|
| Testosterone cypionate | Weekly or twice-weekly injection | Testosterone deficiency confirmed by labs | DEA-registered pharmacy over EPCS |
| Testosterone gel or cream | Daily topical | Testosterone deficiency confirmed by labs | Retail (gel) or 503A (cream), over EPCS |
| Clomiphene citrate | Tablet | Low testosterone in men preserving fertility, off-label | Retail or mail-order generic |
| Anastrozole | Tablet | High estradiol on testosterone therapy, off-label, by lab result | Retail or mail-order generic |
| Estradiol | Patch, gel or tablet | Menopause symptoms | Retail or mail-order generic |
| Micronized progesterone | Capsule | Protecting the uterus during estrogen therapy | Retail or mail-order generic |
| Vaginal estradiol | Cream or insert | Vaginal and urinary symptoms of menopause | Retail or mail-order pharmacy |
| Fezolinetant (Veozah) | Daily tablet | Hot flashes, without hormones; needs liver blood tests | Retail pharmacy |
Left off the list on purpose
Each of these would put the brand's ad accounts, payment accounts or medical licenses at risk.
Compounded hCG
hCG is regulated as a biologic, so pharmacies cannot compound it. Only FDA-approved hCG can be dispensed, and fertility-preserving plans usually use clomiphene instead.
Testosterone for aging alone
Testosterone is prescribed for deficiency confirmed by labs. FDA labeling does not support it for low levels caused by aging alone.
Other anabolic steroids
Performance compounds beyond testosterone are not offered.
Every prescription is the treating provider's decision after an individual evaluation, and a listing here does not mean every patient qualifies. Off-label means FDA has not approved the drug for that use; providers may still prescribe it when clinically appropriate.
PHARMACY
How the medicine gets to patients
Hormone therapy mixes a controlled substance with ordinary generics, so it runs on two kinds of pharmacy.
01
DEA-registered pharmacies for testosterone
Testosterone is a Schedule III controlled substance. Prescriptions go over EPCS to DEA-registered pharmacies licensed in the patient's state.
02
Generics for everything else
Estradiol, progesterone, clomiphene and anastrozole fill as FDA-approved generics through retail or mail-order pharmacies at wholesale cost.
03
503A for custom creams
Testosterone creams and custom-strength hormone creams are compounded by 503A pharmacies against a prescription for one patient.
04
Injection supplies included
Injection programs ship with the syringes, needles and sharps containers the prescription calls for, at room temperature.
0%
Markup on every fill, on every plan
The brand is billed the pharmacy's wholesale invoice. Tessic adds nothing to the medication and takes no share of what the brand charges patients.
COMPLIANCE & ADVERTISING
The rules for selling hormone therapy
What regulators and ad platforms check before a hormone therapy brand can sell and advertise.
What regulators check
01
Testosterone is a controlled substance
Schedule III status means DEA registration in the patient's state, EPCS prescribing and prescription-monitoring checks. Prescribing controlled substances by telehealth without an in-person visit runs on DEA flexibilities currently extended through December 31, 2026, with a permanent rule still pending. Tessic's prescribing workflow follows the rule in force.
02
Treat low levels, not birthdays
FDA requires testosterone labels to say the drug is approved for low testosterone caused by specific medical conditions, and that its safety and benefit for low levels due to aging have not been established. Diagnosis and marketing both have to match.
03
Estrogen risks travel with the benefits
Estrogen products carry label warnings about blood clots, stroke and cancer. Menopause marketing has to present risks alongside benefits.
04
"Bioidentical" is not a safety claim
Compounded bioidentical hormones are not FDA-approved, and a National Academies review found too little evidence that they are safer or work better than approved products. Ads should not suggest they are.
What ad platforms check
01
Testosterone ads get extra review
Ad platforms treat testosterone as a restricted prescription drug. Copy about muscle, sex drive or feeling young again draws rejections; ads can describe the symptoms of deficiency and the lab-based diagnosis.
02
Never ask about the viewer's body
"Is your testosterone low?" breaks Meta's personal-attributes rule. "Testosterone testing and treatment from licensed providers" does not.
03
Careful with transformation photos
Meta restricts before-and-after physiques that promise results, and gym imagery tied to testosterone reads as performance marketing.
Rules for every category
LegitScript certification
Google, Meta and the major card processors check for LegitScript certification before a telehealth brand can advertise prescription treatment or take card payments. Tessic prepares and files the application as part of setup.
Subscription billing
The Restore Online Shoppers' Confidence Act requires the recurring price and terms to be clear before checkout, the buyer's express consent to the charge, and a simple way to cancel.
Health data and ad pixels
Tracking pixels that pass health information to ad platforms have drawn FTC and HHS enforcement. Conversion tracking on a clinic site has to keep intake answers and diagnoses out of what reaches Meta and Google.
Proof behind every claim
The FTC expects competent and reliable scientific evidence behind health claims, and testimonials have to reflect what typical patients experience.
Rules checked September 2026. A planning summary, not legal advice. Rules change, LegitScript sets its own review schedule, and certification is never guaranteed. The brand's own counsel should review its marketing before launch.
LAUNCH TIMELINE
How fast your clinic opens
Hormone brands open within a week. The first prescriptions follow lab results, which usually arrive within days of the draw.
Day 0
Discovery call
The brand chooses men's therapy, menopause therapy or both, plus prices and launch states. Tessic confirms lab and pharmacy coverage.
Days 1-3
Clinic build
Providers are credentialed under the brand with EPCS prescribing set up, hormone intakes and lab panels are loaded, and the storefront goes up. Tessic prepares the LegitScript application.
Days 3-5
Pharmacy and test orders
DEA-registered and generic pharmacy routes are connected, and test orders run from intake through a lab order to a delivered prescription.
Days 5-7
First patients
Patients sign up, book video visits and draw labs. First prescriptions follow once results are in.
After certification
Paid ads
Once LegitScript certification clears, campaigns can run within each platform's rules for restricted prescription drugs.
Timelines assume the brand's name, domain and pricing are ready at the discovery call.
UNIT ECONOMICS
What one patient is worth
A sample model for one patient on a monthly testosterone program at $149 a month. The brand sets the price, medication passes through at wholesale, and Tessic's only per-patient fee is $25 per completed consult.
- Program price, set by the brand
- $149.00
- Testosterone cypionate and supplies, at wholesale (assumed)
- −$30.00
- Provider consults: 4 a year at $25, spread monthly
- −$8.33
- Lab panels, three a year at $90 (assumed)
- −$22.50
- Card processing (3% of price, assumed)
- −$4.47
- Contribution per patient, monthly56% of price, before marketing
- $83.70
12
Patients to cover the Launch plan's $1,000 monthly fee
24
Patients to cover the Grow plan's $2,000 monthly fee
96
Patient-months to earn back the $8,000 Launch setup fee
$8.33
Tessic's monthly fee on this patient, against $23.90 on a 30% markup and 10% revenue-share model
Illustrative only, not a quote or a forecast. The brand sets its own prices; lines marked assumed are sample costs, and the real pharmacy invoice passes through at 0% markup. Contribution is before marketing, the monthly platform fee and taxes. The comparison model applies a 30% medication markup and a 10% revenue share, within the range commonly seen in white-label agreements.
COMMON QUESTIONS
Questions about launching a hormone therapy brand
Yes, over EPCS to DEA-registered pharmacies, after a video visit and a lab-confirmed deficiency. Controlled-substance prescribing follows DEA telemedicine rules and each state's own requirements.
Testosterone patients do: two early-morning total testosterone tests on separate days, plus a blood count and PSA where indicated, drawn at contracted lab sites. Menopause patients get labs when the provider orders them.
Yes. Every plan includes every treatment category, so one brand can run men's and women's hormone programs with separate intakes and pricing.
Only FDA-approved hCG, because hCG is regulated as a biologic and cannot be compounded. Most fertility-preserving plans use clomiphene instead.
The plan's flat monthly fee, $25 per completed consult, and nothing on the medication. Generics and testosterone pass through at the pharmacy's wholesale price, and Tessic takes no revenue share.
OTHER CATEGORIES
Launch in another category
Every plan includes every treatment category, so a brand can add a second one later on the same account.